| DC Field | Value | Language |
|---|
| dc.contributor.author | Yakovleva, E. E. | - |
| dc.contributor.author | Bychkov, E. R. | - |
| dc.contributor.author | Brusina, M. M. | - |
| dc.contributor.author | Piotrovsky, L. B. | - |
| dc.contributor.author | Shabanov, P. D. | - |
| dc.date.accessioned | 2022-05-05T08:58:31Z | - |
| dc.date.available | 2022-05-05T08:58:31Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Pharmacological activity of new imidazole-4,5-dicarboxylic acid derivatives in dopaminergic transmission suppression ttests in mice and rats / E.E. Yakovleva [et al.] // Research Results in Pharmacology. - 2020. - Vol.6, №4.-P. 51-57. - Doi: 10.3897/rrpharmacology.6.57883. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46615 | - |
| dc.description.abstract | To study the antiparkinsonian activity of new 1,2-substituted imidazole-4,5-dicarboxylic acids in dopaminergic transmission suppression tests in mice and rats | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | Parkinson’s disease | ru |
| dc.subject | glutamate | ru |
| dc.subject | NMDA-receptor antagonists | ru |
| dc.subject | antiparkinsonian activity | ru |
| dc.subject | rats | ru |
| dc.subject | mice | ru |
| dc.subject | dopaminergic transmission | ru |
| dc.title | Pharmacological activity of new imidazole-4,5-dicarboxylic acid derivatives in dopaminergic transmission suppression ttests in mice and rats | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 6, № 4
|
